Devin T. Corrigan

PhD candidate in the Zang lab studying novel immune checkpoints and making immunotherapies • NYC • CAR-T cells • Antibodies • Cancer

[Katz Institute for Immunotherapy @IFI_Einstein]

Join us for the IFI-Joint Lab Meeting featuring presentations; @DevinTCorrigan from @xingxing_zang Lab and Divya Kenchappa from Saenger’s Lab!!
Exciting Insights on Cancer Immunotherapy & Immune Cell Regulations!!
@EinsteinPhD
@EinsteinMSTP
@EinsteinMed
@MontefioreNYC

[NextPoint Therapeutics @NextPointTX]

Exciting Preclinical Data on Our Novel B7-H7 T Cell Engager Announced at #SITC2024!
This innovative approach shows promise in overcoming the tumor microenvironment challenges. Can't join us in Houston? Explore the details here: https://t.co/KGQYxIE27D

[Devin T. Corrigan @DevinTCorrigan]

@vinayaka1prasad @xingxing_zang @EinsteinMed @EinsteinPhD Thank you Professor Prasad!

[Devin T. Corrigan @DevinTCorrigan]

Last week I was honored to receive the Barry R. Bloom speaker award for the top Work-in-Progress presentation in the Microbiology and Immunology department. Thank you to my mentor @xingxing_zang for all of your support and guidance! @EinsteinMed @EinsteinPhD

[Albert Einstein College of Medicine - Official @EinsteinMed]

Immunotherapy has revolutionized cancer care. Now @theNCI-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has announced the new Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders. More at https://t.co/UCodavRcxW. 1/2

[XingXing Zang @xingxing_zang]

Nice annual scientific retreat of Montefiore Einstein Comprehensive Cancer Center at the beautiful Glen Island Harbour Club.

[XingXing Zang @xingxing_zang]

Posters of four important and exciting research projects that are led by our lab members Marc Pulanco @MC_Pulanco, Ankit Tanwar @DrAnkitTanwar1, Devin Corrigan @DevinTCorrigan, Zidong (Andy) Li @AndyLi81701371.

[XingXing Zang @xingxing_zang]

As our lab tradition, the whole lab out for lunch to celebrate first birthday of a new lab member @XiaonaSun143635 @MC_Pulanco @DevinTCorrigan @DrAnkitTanwar1 @Miazhang0116 @Yunchao_Shentu @AndyLi81701371 @YulinWang95752 @MissYolandaLiu

[Albert Einstein College of Medicine - Official @EinsteinMed]

Researchers at @theNCI-designated Montefiore Einstein Comprehensive Cancer Center have shown a breakthrough therapy for treating blood cancers can be adapted to treat solid #tumors—an advance that could transform cancer treatment. https://t.co/kqOD82LQEE #CancerResearch #MECCC

[XingXing Zang @xingxing_zang]

I’m thrilled our paper on new CAR treating human solid cancers is out in @ScienceAdvances today. Huge credit to stellar student @einstein_mstp Christopher Nishimura, great collaborators Deyou Zheng @zhengdy and @UTSWMedCenter Cheng Cheng Zhang
https://t.co/KHfK6SsO1T

[XingXing Zang @xingxing_zang]

My thoughts on Chimeric Antigen Receptor (CAR) immune-cell therapy. The next frontier for CAR therapy is solid cancers and autoimmune diseases, also holds promises for aging, Alzheimer’s disease, etc.

The Next Chapter of Science | Technology Networks https://t.co/wFVNhPbA6P

[XingXing Zang @xingxing_zang]

Grateful Oscar Ortiz from SebastianStrong Foundation came to my office and present a check for our CAR research. My lab, David Loeb and Allison Martin are developing next-generation CAR-T therapy treating human pediatric Rhabdomyosarcoma. @EinsteinMed @MontefioreNYC

[XingXing Zang @xingxing_zang]

Great congratulations to NextPoint!!!  It took 10 years moving from our original discovery of HHLA2 as a new B7 immune checkpoint in 2013 to NextPoint’s soon clinical trials in cancer patients. @EinsteinMed @MontefioreNYC

[Albert Einstein College of Medicine - Official @EinsteinMed]

Dr. @Xingxing_Zang develops immune-checkpoint inhibitors (ICIs)—monoclonal antibodies that use the immune system to fight cancer cells. Two of his compounds are in clinical trials. He sees ICIs as the future of #LungCancertreatment. https://t.co/vFpsE31pBg

[XingXing Zang @xingxing_zang]

Thrilled to share a new paper on @Dev_Cell from a fruitful collaboration between @WenjunGuoLab and my lab, showing the Sox9-B7x pathway in @breastcancer immune evasion and a potential new @immunotherapy.
@EinsteinCellBio @EinsteinMed @MontefioreNYC

[Devin T. Corrigan @DevinTCorrigan]

Excited to have received the William R. Jacobs Jr. Award from the Microbiology and Immunology Department at @EinsteinMed. Thank you to my mentor @xingxing_zang for your continued support! @EinsteinPhD

[Acquired Resistance to Therapy Network (ARTNet) @NCIARTNet]

The journey to bring research from the bench to bedside is long but exciting and achievable as shown by @NCIARTNet PI @xingxing_zang @EinsteinMed during his presentation at the NCIARTNet scientific meeting today

[Devin T. Corrigan @DevinTCorrigan]

@LITTL3_RAPP3R @cmachlan @XE0SIS @cnnbrk Wrong https://t.co/znhOqTs68A

[Albert Einstein College of Medicine - Official @EinsteinMed]

In a paper published online today in @jclinicalinvest, an Einstein research team led by Xingxing Zang, https://t.co/d0sPlsGnnn., Ph.D., describes its findings that could bolster the effectiveness of immune-checkpoint therapy. Learn more at: https://t.co/KqFC585MMO
#cancer

[Immunology of Infectious Disease News @infdisease_news]

Elise Ishida & @EinsteinMed researchers generated human IgG monoclonal antibodies to AM/LAM from B cells of two asymptomatic individuals exposed to or latently infected with M. #tuberculosis.

https://t.co/Uh5VK0GcV1